What is the market cap of Gilead Sciences?

About Market Cap. Gilead Sciences has a market cap of $80.69 B, which represents its current share price of $64.66 multiplied by its outstanding share number of 1266.45. As a large-cap company, GILD's shareholders are exposed to the least amount of risk. The company's Market Capitalization is a measurement of company size.

Where is Gilead Sciences Inc headquartered?

The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA. GILD | Complete Gilead Sciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

What does Gilead Sciences Inc (gild) do?

The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome,... View the latest Gilead Sciences Inc. (GILD) stock price, news, historical charts, analyst ratings and financial information from WSJ.